Allianz Asset Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-15,400
Closed -$786K 2397
2024
Q4
$786K Buy
15,400
+2,192
+17% +$108K ﹤0.01% 1720
2024
Q3
$545K Hold
13,208
﹤0.01% 1834
2024
Q2
$636K Sell
13,208
-5,793
-30% -$257K ﹤0.01% 1755
2024
Q1
$912K Sell
19,001
-85
-0.4% -$4.54K ﹤0.01% 1445
2023
Q4
$1.24M Buy
19,086
+1,921
+11% +$116K ﹤0.01% 1516
2023
Q3
$1.12M Sell
17,165
-754
-4% -$47.4K ﹤0.01% 1665
2023
Q2
$1.04K Buy
17,919
+13,860
+341% +$874K ﹤0.01% 2045
2023
Q1
$251K Buy
+4,059
New +$244K ﹤0.01% 2019
2022
Q3
Sell
-11,275
Closed -$767K 2166
2022
Q2
$767K Sell
11,275
-598
-5% -$43K ﹤0.01% 1767
2022
Q1
$1.08M Sell
11,873
-42,438
-78% -$3.47M ﹤0.01% 1835
2021
Q4
$4.96M Sell
54,311
-133
-0.2% -$11.4K ﹤0.01% 1242
2021
Q3
$4.42M Buy
54,444
+38,876
+250% +$3.27M ﹤0.01% 1329
2021
Q2
$1.45M Buy
+15,568
New +$1.51M ﹤0.01% 1597

Other funds holding NARI

Allianz Asset Management's NARI Position: Q1 2025 in Review

Allianz Asset Management sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 15,400 shares — an estimated $786K sold.

Allianz Asset Management first reported a position in NARI in Q2 2021 and held it in 13 quarters. The position peaked at $4.96M in Q4 2021. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Allianz Asset Management reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Allianz Asset Management sold 15,400 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $786K.
  • Allianz Asset Management first reported a position in Inari Medical, Inc. Common Stock in Q2 2021 and held it in 13 quarters.
  • Allianz Asset Management's Inari Medical, Inc. Common Stock position peaked at $4.96M in Q4 2021.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Allianz Asset Management's 13F filing for Q1 2025, filed 5 May 2025.